Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

Fabrizio Vernieri; Claudia Altamura; Cinzia Aurilia; Nicoletta Brunelli; Gabriella Egeo; Luisa Fofi; Carmelina Maria Costa; Adriana Fallacara; Valentina Favoni; Giulia Pierangeli; Marco Aguggia; Davide Bertuzzo; Maria Albanese; Paola Di Fiore; Fabio Frediani; Sabina Cevoli; Piero Barbanti

doi:10.1007/s10072-020-04669-y

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

Fabrizio Vernieri, Claudia Altamura, Cinzia Aurilia, Nicoletta Brunelli, Gabriella Egeo, Luisa Fofi, Carmelina Maria Costa, Adriana Fallacara, Valentina Favoni, Giulia Pierangeli, Marco Aguggia, Davide Bertuzzo, Maria Albanese, Paola Di Fiore, Fabio Frediani, Sabina Cevoli, Piero Barbanti

Istituto Scienze Neurologiche

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	487-488
Number of pages	2
Journal	Neurological Sciences
Volume	41
DOIs	https://doi.org/10.1007/s10072-020-04669-y
Publication status	Published - Dec 2020

ASJC Scopus subject areas

Dermatology
Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1007/s10072-020-04669-y

Cite this

Vernieri, F., Altamura, C., Aurilia, C., Brunelli, N., Egeo, G., Fofi, L., Costa, C. M., Fallacara, A., Favoni, V., Pierangeli, G., Aguggia, M., Bertuzzo, D., Albanese, M., Di Fiore, P., Frediani, F., Cevoli, S., & Barbanti, P. (2020). Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). Neurological Sciences, 41, 487-488. https://doi.org/10.1007/s10072-020-04669-y

Vernieri, F, Altamura, C, Aurilia, C, Brunelli, N, Egeo, G, Fofi, L, Costa, CM, Fallacara, A, Favoni, V , Pierangeli, G, Aguggia, M, Bertuzzo, D, Albanese, M, Di Fiore, P, Frediani, F, Cevoli, S & Barbanti, P 2020, 'Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)', Neurological Sciences, vol. 41, pp. 487-488. https://doi.org/10.1007/s10072-020-04669-y

@article{3243664d2a6b46ffb38b18578b43b699,

title = "Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)",

author = "Fabrizio Vernieri and Claudia Altamura and Cinzia Aurilia and Nicoletta Brunelli and Gabriella Egeo and Luisa Fofi and Costa, {Carmelina Maria} and Adriana Fallacara and Valentina Favoni and Giulia Pierangeli and Marco Aguggia and Davide Bertuzzo and Maria Albanese and {Di Fiore}, Paola and Fabio Frediani and Sabina Cevoli and Piero Barbanti",

note = "Ricercatore distaccato presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (Pierangeli Giulia, Favoni Valentina) ",

year = "2020",

month = dec,

doi = "10.1007/s10072-020-04669-y",

language = "English",

volume = "41",

pages = "487--488",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia s.r.l.",

}

TY - JOUR

T1 - Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

AU - Vernieri, Fabrizio

AU - Altamura, Claudia

AU - Aurilia, Cinzia

AU - Brunelli, Nicoletta

AU - Egeo, Gabriella

AU - Fofi, Luisa

AU - Costa, Carmelina Maria

AU - Fallacara, Adriana

AU - Favoni, Valentina

AU - Pierangeli, Giulia

AU - Aguggia, Marco

AU - Bertuzzo, Davide

AU - Albanese, Maria

AU - Di Fiore, Paola

AU - Frediani, Fabio

AU - Cevoli, Sabina

AU - Barbanti, Piero

N1 - Ricercatore distaccato presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (Pierangeli Giulia, Favoni Valentina)

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85089870389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089870389&partnerID=8YFLogxK

U2 - 10.1007/s10072-020-04669-y

DO - 10.1007/s10072-020-04669-y

M3 - Article

C2 - 32845481

AN - SCOPUS:85089870389

VL - 41

SP - 487

EP - 488

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

ER -

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this